TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Terumo Corporation. The primary component is Anhydrous Citric Acid; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Dextrose Monohydrate; Adenine.
| Product ID | 53877-001_05957b63-ef61-4c95-b683-7bb697ae2a89 |
| NDC | 53877-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) |
| Generic Name | Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2012-05-22 |
| Marketing Category | NDA / NDA |
| Application Number | BN820528 |
| Labeler Name | Terumo Corporation |
| Substance Name | ANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; DEXTROSE MONOHYDRATE; ADENINE |
| Active Ingredient Strength | 3 g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL |
| Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-05-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-14 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-16 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-10 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-14 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-11-18 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-05-22 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-10 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-14 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-16 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-14 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-14 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-05-22 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-05-22 |
| Marketing Category | NDA |
| Application Number | BN820528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-05-22 |
| Ingredient | Strength |
|---|---|
| ANHYDROUS CITRIC ACID | 2.99 g/1000mL |
| SPL SET ID: | 6b6f4a15-7bb0-4092-b43d-b423f14ec12f |
| Manufacturer | |
| UNII |